Autoimmune And Rheumatic Diseases

WASHINGTON — Despite the heated “rhetoric” regarding diversity, equity and inclusion efforts, the idea that predominantly white organizations are resentful of DEI programs is incorrect, according to the ACR Convergence 2024 keynote speaker.

Despite a lack of “gold standard” evidence surrounding cannabis use for musculoskeletal pain, rheumatologists must not turn a blind eye to how such products are used by their patients in the real world, according to researchers.

It’s that time of year again.

A simple educational program on antinuclear antibody testing in non-rheumatology departments led to fewer unnecessary tests and a higher positivity rate, reflecting better patient selection, according to a study in Clinical Rheumatology.

Patients with autoimmune or inflammatory rheumatic diseases living in rural areas demonstrate a 24% higher mortality risk after SARS-CoV-2 infection vs. those in urban areas, according to data published in Arthritis Care & Research.

From a young age, I was fascinated by the human body and its complexities. Growing up in a small village in southern Italy, I had an insatiable curiosity about science and how we experience pain, heal and recover.

Unexplained chorea, especially among women, should prompt testing for antibodies associated with antiphospholipid syndrome, according to data published in Lupus Science & Medicine.

This month’s cover story is both enlightening and distressing.

Telemedicine access and use in rheumatology has fluctuated wildly over the last half decade, from near nonexistence through 2019 to its highwater mark during the emergency phase of the COVID-19 pandemic.

New diagnoses of autoimmune diseases were not overall more likely among vaccinated patients infected with omicron or delta variants of COVID-19, compared with those not infected, according to data published in JAMA Network Open.